Infinimmune Secures $75 Million in Latest Series A Funding Round

Infinimmune secured $75 million in its latest Series A, adding another data point to the FinTech funding market.

Infinimmune Raises $75 million in Funding

Inside the AD Pipeline: Infinimmune Raises $75 Million Series A to Advance Its AD Candidates.

Investors Behind the Funding

The round was backed by Regeneron Ventures. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Infinimmune operates in FinTech. Infinimmune's financing adds to recent private-market activity.

Strategic Use of Funds

Advance Its AD Candidates

Looking Ahead

Inside the AD Pipeline: Infinimmune Raises $75 Million Series A to Advance Its AD Candidates

Source reference: original announcement/article.